Crossmark

Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence

Published Online: 2022-01-06

Published Print: 2022-02

Authors

Wang, Yongmei

Jing, Fanbo

Wang, Haibo
Funding

Funding for this research was provided by:

Pfizer Medical Affairs, Shanghai, China
License Information

Text and Data Mining valid from 2022-01-06

Version of Record valid from 2022-01-06
More Information

Article History

Received: 2 August 2021

Accepted: 14 September 2021

First Online: 6 January 2022

Document is current